Another B-Cell Drug for Lupus Hits the Mark

(MedPage Today) — Obinutuzumab (Gazyva) appears set to add systemic lupus erythematosus (SLE) to its list of approved indications, as results from a phase III trial showed it was significantly more effective than placebo, with no new safety concerns…